ZIRGAN 1.5 mg/g

ZIRGAN 1.5 mg/g is an ophthalmic gel containing ganciclovir, used for treating viral eye infections. This gel is applied topically to the eye and is manufactured by Bausch & Lomb Incorporated in the USA.

ZIRGAN 1.5 mg/g is primarily used for the treatment of viral eye infections, specifically cytomegalovirus (CMV) retinitis. This ophthalmic gel is applied directly to the eye to help manage and control the infection. The active ingredient, ganciclovir, works to inhibit the replication of the virus, providing relief and aiding in the healing process. What is ZIRGAN used for? It is commonly prescribed for patients with CMV retinitis, a condition that can lead to vision loss if left untreated.

When applied as directed, ZIRGAN 1.5 mg/g may cause temporary blurred vision, eye irritation, or discomfort. These effects are generally mild and should subside as your eyes adjust to the medication. If you experience persistent or severe side effects, it is important to consult your healthcare provider.

Always follow the instructions provided by your healthcare provider when using ZIRGAN 1.5 mg/g. Avoid touching the tip of the applicator to prevent contamination. If you wear contact lenses, remove them before applying the gel and wait at least 15 minutes before reinserting them. Store the gel at room temperature and keep it out of reach of children.

ZIRGAN 1.5 mg/g may interact with other medications, particularly those that affect the immune system. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions. Avoid using other eye medications unless directed by your healthcare provider.